In the largest deal, worth US $2.14m, iSOFT agreed to continue supporting its patient administration system (PAS) with Frimley Park Hospital NHS Foundation Trust in Surrey, England, for a further three years. The agreement demonstrates iSOFT’s commitment to directly servicing customers in the south of England under recent changes to the National Programme for IT, which allow hospital trusts in the southern region to engage directly with iSOFT. Frimley Park is the fifth NHS trust in southern England this year to extend support agreements after upgrading to the latest version of PatientCentre PAS.

iSOFT entered the Peru market with a US $1192034 contract for a hospital information system (HIS) at six private hospitals in the Lima region. The deal, which boosts the company’s global footprint to 40 countries, follows agreements with Mexico and Honduras in the past year as it seeks growth opportunities in Latin America.

In Germany, iSOFT won orders with two new customers totaling US $1.57m. Kreiskrankenhaus Frankenberg has committed to iSOFT’s HIS for six years. Klinik Vincentinum, Augsburg, agreed on a five-year contract for a radiology information system in a license-only deal. In the Netherlands, iSOFT agreed on a services contract worth more than US $726,850.

In Australia, iSOFT won orders worth US $1.66m as Victoria Health continues to implement iSOFT’s i.Patient Manager solution in acute care and community care settings across the state. To date iSOFT and Victoria Health have implemented i.PM in seven agencies, with an additional three currently in progress.

‘These contracts demonstrate iSOFT’s strategy of strengthening our presence in our core markets in Australia, Europe and the U.K, while at the same time leveraging our global brand by securing new customers in identified growth markets in Latin America,’ said Gary Cohen, utive Chairman and CEO.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.